Clinical Trial Update: The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating SHR3824 in combination with metformin for Type 2 Diabetes Mellitus. The study assesses PK/PD, preliminary efficacy sign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN